BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38066300)

  • 21. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
    Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
    Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
    Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
    Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
    Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
    J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer.
    Liu Y; Fang Y; Bao L; Wu F; Wang S; Hao S
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
    Leontovich AA; Zhang S; Quatraro C; Iankov I; Veroux PF; Gambino MW; Degnim A; McCubrey J; Ingle J; Galanis E; D'Assoro AB
    Int J Oncol; 2012 Jun; 40(6):1858-64. PubMed ID: 22447278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.
    Wang M; Wu Y; Li X; Dai M; Li S
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
    Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
    Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.
    Scheel C; Weinberg RA
    Semin Cancer Biol; 2012 Oct; 22(5-6):396-403. PubMed ID: 22554795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
    Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
    EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel single-cell based method for breast cancer prognosis.
    Li X; Liu L; Goodall GJ; Schreiber A; Xu T; Li J; Le TD
    PLoS Comput Biol; 2020 Aug; 16(8):e1008133. PubMed ID: 32833968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
    Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.
    Li H; Chen X; Gao Y; Wu J; Zeng F; Song F
    Cell Signal; 2015 Jan; 27(1):82-9. PubMed ID: 25280941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.
    Zhan Y; Li X; Liang X; Li L; Cao B; Wang B; Ma J; Ding F; Wang X; Pang D; Liu Z
    Oncotarget; 2017 Jan; 8(3):4629-4641. PubMed ID: 27894095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer.
    Ghauri MA; Su Q; Ullah A; Wang J; Sarwar A; Wu Q; Zhang D; Zhang Y
    Phytomedicine; 2021 Apr; 84():153500. PubMed ID: 33626427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.
    Palma Cde S; Grassi ML; Thomé CH; Ferreira GA; Albuquerque D; Pinto MT; Ferreira Melo FU; Kashima S; Covas DT; Pitteri SJ; Faça VM
    Mol Cell Proteomics; 2016 Mar; 15(3):906-17. PubMed ID: 26764010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.
    Punzi S; Balestrieri C; D'Alesio C; Bossi D; Dellino GI; Gatti E; Pruneri G; Criscitiello C; Lovati G; Meliksetyan M; Carugo A; Curigliano G; Natoli G; Pelicci PG; Lanfrancone L
    Breast Cancer Res; 2019 Nov; 21(1):123. PubMed ID: 31752957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.